Please assess the completion status of the following clinical trial:

Trial Title: Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion criteria:~* Biological profile suggesting hepcidin deficiency:~  * high serum iron (\> 25μmol / l) checked at least 2 times.~ * increased transferrin saturation coefficient (\> 50 %) checked at least 2 times, and calculated from transferrinemia.~* Proved hepatic iron overload: using a dosage of iron hepatic concentration either on hepatic biopsy, or by MRI according to the method of iron overload quantification. A threshold of 100 µmol / g is set.~* Patient's written consent for examination and collection of genetic data to set the diagnosis.~Non inclusion criteria:~* HFE hemochromatosis: C282Y/C282Y homozygosity~* Treatment by iterative phlebotomies (more than 2 phlebotomies)~* Hematological diseases with dyserythropoiesis and/or repeated transfusions~* Low haptoglobin level, suggesting chronic hemolysis or myelodysplasia~* Long-term iron oral and/or parenteral supplementation

- Gender: ALL
- Minimum Age: None
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- iron overloads except C282Y homozygosity (Type: None): Patients with an iron overloads except C282Y homozygosity

Based on this trial design, predict the completion outcome and termination type (if applicable).